These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26622883)

  • 21. Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.
    Roy R; Louis G; Loughlin KR; Wiederschain D; Kilroy SM; Lamb CC; Zurakowski D; Moses MA
    Clin Cancer Res; 2008 Oct; 14(20):6610-7. PubMed ID: 18927302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma.
    Gerhards S; Jung K; Koenig F; Daniltchenko D; Hauptmann S; Schnorr D; Loening SA
    Urology; 2001 Apr; 57(4):675-9. PubMed ID: 11306379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 are biomarkers for the detection of colon tubular adenocarcinoma.
    Yuan JH; Xie LS; Zhu YH; Wang XH; Zhang YJ; Wang XJ
    World J Gastrointest Oncol; 2021 Oct; 13(10):1506-1517. PubMed ID: 34721781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.
    Kiczak L; Tomaszek A; Bania J; Paslawska U; Zacharski M; Janiszewski A; Rybinska I; Dziegiel P; von Haehling S; Ardehali H; Jankowska EA; Ponikowski P
    J Physiol Pharmacol; 2014 Jun; 65(3):365-75. PubMed ID: 24930508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix Metalloproteinase Neutrophil Gelatinase-Associated Lipocalin Complex Predicts Atrial Fibrillation Recurrence after Electrical Cardioversion in Obese Patients.
    Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Waszkiewicz E; Bachorzewska-Gajewska H; Malyszko J; Michniewicz E; Dobrzycki S; Musial WJ
    Cardiorenal Med; 2016 Nov; 7(1):11-20. PubMed ID: 27994598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study.
    Yamashita T; Doi K; Hamasaki Y; Matsubara T; Ishii T; Yahagi N; Nangaku M; Noiri E
    Crit Care; 2014 Dec; 18(6):716. PubMed ID: 25524453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postpartum human breast milk levels of neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9)/NGAL complex in normal and pregnancies complicated with insulin-dependent gestational diabetes mellitus. A prospective pilot case-control study.
    Metallinou D; Lykeridou K; Karampas G; Liosis GT; Skevaki C; Rizou M; Papassotiriou I; Rizos D
    J Obstet Gynaecol; 2020 May; 40(4):461-467. PubMed ID: 31353996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
    Li C; Zhang Z; Peng Y; Gao H; Wang Y; Zhao J; Pan C
    PLoS One; 2019; 14(8):e0220841. PubMed ID: 31387110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum tissue inhibitor of metalloproteinase-2 (TIMP-2) and matrix metalloproteinase-2 in complex with the inhibitor (MMP-2:TIMP-2) as prognostic markers in bladder cancer.
    Vasala K; Turpeenniemi-Hujanen T
    Clin Biochem; 2007 Jun; 40(9-10):640-4. PubMed ID: 17374529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic biomarkers of microvascular alterations in type 1 diabetes associated neuropathy and nephropathy - A prospective long-term follow-up study.
    Baldimtsi E; Whiss PA; Wahlberg J
    J Diabetes Complications; 2023 Dec; 37(12):108635. PubMed ID: 37989066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
    You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
    Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diurnal variation of matrix metalloproteinase-9 and its associated factors in human tears.
    Markoulli M; Papas E; Cole N; Holden BA
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1479-84. PubMed ID: 22323468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NGAL/MMP-9 as a Biomarker for Epithelial Ovarian Cancer: A Case-Control Diagnostic Accuracy Study.
    Gupta RK; Dholariya S; Radadiya M; Agarwal P
    Saudi J Med Med Sci; 2022; 10(1):25-30. PubMed ID: 35283706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of urine neutrophil gelatinase-associated lipocalin molecular forms and their association with different urinary diseases in cats.
    Wu PH; Hsu WL; Tsai PJ; Wu VC; Tsai HJ; Lee YJ
    BMC Vet Res; 2019 Aug; 15(1):306. PubMed ID: 31455336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
    Grignon DJ; Sakr W; Toth M; Ravery V; Angulo J; Shamsa F; Pontes JE; Crissman JC; Fridman R
    Cancer Res; 1996 Apr; 56(7):1654-9. PubMed ID: 8603416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
    Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
    Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.
    Bchir S; Nasr HB; Bouchet S; Benzarti M; Garrouch A; Tabka Z; Susin S; Chahed K; Bauvois B
    J Cell Mol Med; 2017 Jul; 21(7):1280-1291. PubMed ID: 28004483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
    Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.